Coeptis Therapeutics
Price & Volume
Stats
See more52W Range | $6.80-$21.41 |
Market Cap | $102M |
Shares Short | 429,801 |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | 1,563.7% |
Gross Profit (12 Mos) | $1.1M |
Diluted EPS | -$2.81 |
News
See moreYahoo Finance • 24 days ago
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application
Yahoo Finance • 7 months ago
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders
Yahoo Finance • 7 months ago
ACT NOW: The M&A Class Action Firm Continues to Investigate the Merger – BFIN, ARIS, CIO and COEP
Yahoo Finance • 7 months ago
Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating
About
CEO | Mr. David Mehalick |
Address | 105 Bradford Rd, Wexford, PA, United States, 15090 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |